The dominant role of G12C over other KRAS mutation types in the negative prediction of efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in non–small cell lung cancer
Fiala, Ondrej, Pesek, Milos, Finek, Jindrich, Benesova, Lucie, Belsanova, Barbora, Minarik, MarekVolume:
206
Language:
english
Journal:
Cancer Genetics
DOI:
10.1016/j.cancergen.2012.12.003
Date:
January, 2013
File:
PDF, 277 KB
english, 2013